番茄社区app

Trial from China provides proof-of-concept for stroke risk reduction in symptomatic cases

Continued OAC failed to meet noninferiority in POPular PAUSE TAVI

More conclusive evidence for benefits on Afib burden, QoL

Bleeding reduced -- without risk of ischemic events -- versus dual antithrombotic in Korean trial

No benefit to beta-blocker interruption among MI survivors using them for secondary prevention

Researchers suggest various explanations for provocative finding

Health news and commentary gathered by 番茄社区app staff

Successful reperfusion associated with good functional outcomes regardless of age

Predictors of POAF burden, late-occurring POAF identified in prospective study

Experts put SELECT trial findings in context

Also in TTHealthWatch: OUD medication use, and heart disease trends in the U.K.

Also in TTHealthWatch: managing obesity in children and adolescents

Calling an end to debate rarely serves the advancement of knowledge

TRACE-III trial finds benefit for lytic given up to 24 hours after stroke onset